MetaCap

Trinity Biotech Statistics

NASDAQ: TRIBHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

6.24+0.755 (+13.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Trinity Biotech by the numbers

Trinity Biotech has a market capitalization of $5.1 million based on 813.13K shares outstanding. With trailing EPS of $-60.00, Trinity Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.4% below its 50-day average and 55.6% below its 200-day average.

Average daily trading volume is 13.54K shares, or about $84,471 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TRIB valuation vs. peer median

TRIB compared with the median of 8 peer companies
MetricTRIBPeer medianDifference
Market cap$5.07M$5.41M-6%
Avg. volume13.54K195.12K-93%

Peer median across 8 companies: BMRA, CDIO, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.

Valuation

Price / sales (latest FY)
0.08
EPS (TTM)
$-60.00

Price and trading

Previous close
5.49
Open
5.01
Day range
4.54 – 6.24
52-week range
4.54 – 52.50
Beta
—
Volume
13.79K

Dividends and events

Annual dividend
None
Next earnings date
Dec 22, 2026

Additional statistics

Market Cap
5.07M
Forward Pe
-6.06
Eps
-60.00
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
52.50
Week52 Low
4.54
Avg Volume
13,537.00
Shares Outstanding
813.13K
Ma50
6.67
Ma200
14.06
Earnings Date
Dec 22, 2026
Pct From52w High
-88.11%
Pct From52w Low
37.60%

Related